Itaru IMAYOSHI
Hes7 K14R knock-in mice. The 14th residue of Hes7 gene was replaxced by arginine.
条件を付加する。<br>研究成果の公表にあたって寄託者の指定する文献を引用する。Nat Genet. 2004 36(7):750-4.<br>研究成果の公表にあたって謝辞の表明を必要とする。<br>学術機関の学術研究に限る。分与希望者は事前に 影山龍一郎 (E-mail: rkageyam@virus.kyoto-u.ac.jp) に連絡をとり、分与に関して許可を得ること。(提供承諾書(書式6)の提出は不要)。
Bacteriophage P1 loxP sequence, mouse Hes7 genomic DNA
D (more than 6 months)
ICR.Cg-Hes7<tm2Kag>
ICR.Cg-Hes7<tm2Kag>
影山龍一郎
今吉 格
true
RBRC05985
TT2 [(C57BL/6NCrlj x CBA/JNCrlj)F1]
Heterozygote x Wild-type [or Crossing to Slc:ICR]
Heterozygote x Wild-type [or Crossing to Slc:ICR]
Necessary documents for ordering:<ol><li>Order form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_4.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_b.docx">English</A>)</li><li>Category I MTA: MTA for distribution with RIKEN BRC (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_5.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_c.docx">English</A>)</li><li>Acceptance of responsibility for living modified organism (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_7.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_g.docx">English</A>)</li></ol>
Hes7 K14R ; Hes7/K14R KI
Hes7 K14R ; Hes7/K14R KI
D(6か月以上)
Cre/loxP system
Hes7遺伝子の14番目のリジンをアルギニンに置換したノックインマウス。
Ryuichiro KAGEYAMA
京都大学ウィルス研究所・影山龍一郎(2003)。TT2 ES細胞由来を用いて作出。ICRと交配。
Developed by Ryoichiro Kageyama, Institute for Virus Research, Kyoto University in 2003. TT2 ES cells were used. The mutant mice were crossed to ICR.
In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Nat Genet. 2004 36(7):750-4.In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. The RECIPIENT of BIOLOGICAL resource shall obtain a prior written consent on use of it from the DEPOSITOR Dr. Ryoichiro Kageyama (E-mail: rkageyam@virus.kyoto-u.ac.jp ). (No approval form (Form D) is necessary).